28 July 2017
1QFY18 Results Update | Sector: Telecom
Idea Cellular
Buy
BSE SENSEX
32,310
S&P CNX
10,015
CMP: INR96
TP: INR110 (+15%)
Motilal Oswal values your support in
the Asiamoney Brokers Poll 2017 for
India Research, Sales and Trading
team. We
request your ballot.
Latent synergies to bolster growth
Flat consolidated revenues – a solace to Idea:
Marred by disruption in the
sector over the last two quarters, Idea’s revenue for 1QFY18 came in flat QoQ
(-14% YoY) at INR81.7b. Recovery in voice revenue growth to 2% QoQ (to
INR61b) was offset by data revenue decline of 7% QoQ (to INR13.7b). The risk
of down-trading due to unlimited price plans was offset by traffic recovery led
by end of RJio’s free usage offer. Subsequently, ARPU stabilized to INR141 from
INR142 in the quarter. The key negative in Idea’s result is the continued fall in
data subscribers (10% QoQ), which can be ascribed to broadband subscriber
churn due to their migration to 4G devices.
EBITDA declines 11.5%,
commensurating estimate
QoQ:
Overall revenues
recovered from the lows, but EBITDA continued to decline (-12%QoQ or -39%
YoY to INR18.8b), largely due to higher network expenses (+6%QoQ) and
roaming and access charges. Consequently, margin shrunk 300bp QoQ
(-970bpYoY), and net loss widened QoQ to INR8.1b from INR3.3b.
Silver linings to the cloud:
We believe competitiveness in the industry is likely
to bottom out by end-FY18 and that RJio’s VoLTE offering is not price-
disruptive. VoLTE network launch by incumbents and improving handset
ecosystem may leave only 3-4 telecom players in the market. The CCI approval
for Vodafone-Idea merger will: (1) allow them to plan the network synergies
sooner, 2) reduce the gestation period and 3) create a strong competitive
position in the market.
Maintain Buy with TP of INR 110:
Idea is valued at 9x EV/EBITDA on FY19E,
which partly captures the gains from Vodafone merger. The estimated back-
ended synergy gains (not yet modeled in our numbers) in FY20 value the stock
at 6.8x on FY20E. Gains from tower sale may provide further upside. We
maintain
Buy
with TP of INR110 on 9.5x FY19E EV/EBITDA. However, the
merger, as well as its timelines, remains a key risk to our rating.
FY17
2Q
3Q
93,002 86,627
7.0
-3.9
64,601 64,973
28,401 21,655
30.5
25.0
19,543 19,653
1,057 1,143
8,753 9,232
1,162 -6,087
1,162 -6,087
247 -2,248
21.3
36.9
915 -3,839
-88.7 -150.2
1.0
-4.4
FY18
2QE
3QE
84,531 87,974
-9.1
1.6
64,590 66,687
19,941 21,286
23.6
24.2
21,348 21,889
834
851
11,131 11,131
-11,704 -10,882
-11,704 -10,882
0
0
0.0
0.0
-11,704 -10,882
-1,379.6 183.5
-13.8 -12.4
FY17
355,758
12.7
252,995
102,763
28.9
78,272
4,218
37,342
-8,633
-8,633
-4,636
53.7
-3,997
-117.3
-1.1
FY18E
346,806
-2.5
262,618
84,188
24.3
86,461
3,371
44,932
-43,833
-43,833
-4,497
10.3
-39,336
884.1
-11.3
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm
Free float (%)
IDEA IN
3,601
344.0 / 5.4
124 / 66
13/7/-24
1692
57.6
Financials & Valuations (INR b)
Y/E Mar
2017 2018E 2019E
Net Sales
355.8 346.8 368.7
EBITDA
102.8
84.2
95.0
Adj PAT
-4.0 -39.3 -40.8
EPS (INR)
-1.1 -10.9 -11.3
Gr. (%)
-116.2 884.1
3.6
BV/Sh (INR)
68.6
57.7
46.4
RoE (%)
-1.6 -17.3 -21.7
RoCE (%)
1.5
-0.3
0.3
P/E (x)
-86.2
-8.8
-8.5
P/BV (x)
EV/EBITDA (x)
Estimate change
TP change
Rating change
1.4
8.1
1.7
10.0
2.1
9.0
Quarterly Performance (INR m)
Y/E March
Gross Revenue
YoY Change (%)
Total Expenditure
EBITDA
Margins (%)
Depreciation
Share in Profits from Associates
Net Finance Costs
PBT before EO expense
PBT
Tax
Rate (%)
Reported PAT
YoY Change (%)
Margins (%)
1Q
94,866
7.9
63,917
30,949
32.6
19,192
1,035
9,431
3,361
3,361
1,158
34.5
2,203
-74.2
2.3
4Q
81,261
-14.3
60,062
21,199
26.1
19,885
983
9,366
-7,069
-7,069
-3,792
53.6
-3,277
-156.9
-4.0
1Q
81,665
-13.9
62,911
18,754
23.0
20,679
818
11,539
-12,646
-12,646
-4,497
35.6
-8,149
-469.9
-10.0
4QE
92,073
13.3
68,398
23,675
25.7
22,545
868
11,131
-9,133
-9,133
0
0.0
-9,133
178.7
-9.9
1QFY18E Variance %
2.5
79,689
-16.0
60,713
3.6
-1.2
18,977
23.8 -85 bp
-0.9
20,857
1,003
-18.4
9.8
10,513
-11,391
11.0
-14,291
-11.5
49.9
-3,000
26.3 922 bp
-2.9
-8,391
-2.3
-480.9
-10.5 -55 bp
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
Aliasgar Shakir - Research analyst
(Aliasgar.Shakir@motilaloswal.com); +91 22 3982 5423
Hafeez Patel - Research analyst
Hafeez.Patel@motilaloswal.com); +91 22 3010 2611